Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News Warrent Extension

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Sep 22, 2024 8:14am

131 Views

Post# 36235222

RE:RE:News Warrent Extension

Those warrants were from a PP I participated in. I believe RW and his wife had bought in with a very significant amount of ove $500 K. Glad they extended them.

Infinity wrote: This warrant extension is meaningless to me, Majority of the beneficiaries are the current management. These were just rewards. Not for participation in any private placements. They were just being rewarded for not risking their own money and being supportive. IMO

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals